Skip to main content
Premium Trial:

Request an Annual Quote

CDC's Infectious Disease Centers to Use DNAStar's Sequence Software

NEW YORK (GenomeWeb News) – The US Centers for Disease Control and Prevention has licensed DNAStar’s sequence analysis software for use at several of its facilities, the bioinformatics company said today.
 
The multi-site license agreement allows the CDC’s Coordinating Center for Infectious Disease to use the company’s Lasergene software at its Atlanta base and at its campuses in Colorado, Alaska, and in Puerto Rico.
 
The Lasergene software includes assembly, visualization, and analysis tools for traditional and next-generation sequencing data, DNAStar said. 
 
The CCID includes the National Center for Immunization and Respiratory Disease; the National Center for Zoonotic, Vector Borne and Enteric Disease; the National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention; and the National Center for Preparedness, Control and Prevention of Infectious Diseases.
 
Financial terms of the agreement were not released.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.